Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
California Hospital Association

2. Address

Address1
1215 K STREET, #700
 Address2
​
City
SACRAMENTO
 State
CA
 Zip Code
95814
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mrs.
​Carrie Bergerot
​9165527644
​cbergerot@calhospital.org
5. Senate ID#
​7747-12
7. Client Name Self Check if client is a state or local government or instrumentality
​California Hospital Association
6. House ID#
​334020000
TYPE OF REPORT 8. Year
​2024
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​420,000.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Anne O'Rourke
 Date
7/18/2024 2:02:33 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

Q2 Lobbying Report (April 1-June 30)

HCR
Transparency (surprise medical bills; public posting of hospital charges)
340B Drug Pricing Program
Resident Physician Shortage Act of 2023 (H.R. 2389)
No Surprises Act regulations
Food and Drug Amendments
No Surprise Bills for New Moms Act (H.R. 3387)
Securing the U.S. Organ Procurement and Transplantation Network Act (H.R. 2544)
Promoting Access to Treatments and Increasing Extremely Needed Transparency Act (H.R. 3561)
Medicaid VBPs for Patients (MVP) Act (H.R. 2666)
Providers and Payers COMPETE Act (H.R. 3284)
To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program (H.R. 3290)
Transparent PRICE Act (H.R. 3281/H.R. 2691))
Resident Physician Shortage Reduction (S. 1302)
Medical Student Education Authorization Act (H.R. 3046)
Save Americas Rural Hospitals Act (H.R. 833)
Chronic Care Management Improvement Act (H.R. 2829)
Safety From Violence for Healthcare Employees Act (H.R. 2584)
Supporting Safety Net Hospitals Act (H.R. 2665)
Patient Access to Higher Quality Health Care Act (H.R. 977/S.470)
FEMA re: COVID-19 related reimbursement
Public Health Guidance Transparency and Accountability Act of 2023 (H.R. 4529)
Public Health Emergency Congressional Review Act (H.R. 4381)
CDC Leadership Accountability Act of 2023 (H.R. 3813)
Preparing for All Hazards and Pathogens Reauthorization Act (H.R. 4421)
Preparedness and Response Reauthorization Act (H.R. 4420)
Childrens Hospital GME Support Reauthorization Act of 2023 (H.R. 3887)
Health Care Price Transparency Act of 2023 (H.R. 4822)
Providers and Payers COMPETE Act (H.R. 3284)
Lower Costs, More Transparency Act (H.R. 5378
Transparency in Coverage Act (H.R. 4507)
GOLD Card Act of 2023 (H.R. 4968)
No Fees for EFTs Act (H.R.6487)
Rural Health Care Facilities Revitalization Act (H.R. 5989)
Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (H.R. 7153)
To amend title XVIII of the Social Security Act to establish a definition of essential health system in statute (H.R. 7397)
Substance Use Disorder Workforce Act (H.R. 7050)
340B PATIENTS Act (H.R. 7635)
The 340B Affording Care for Communities and Ensuring a Strong Safety-net (ACCESS) Act (H.R. 8574)
Improving Seniors Access to Timely Care Act (H.R. 8702/S.4532)
The Preserving Emergency Access in Key Sites (PEAKS) Act (H.R. 7931)
Rural Health Care Facilities Revitalization Act (H.R. 5989)

MMM
Accelerated and Advance Payment Program repayment flexibility
Graduate Medical Education (GME) funding
Telehealth flexibilities and payment
Annual Prospective Payment System Rules
Organ acquisition payment policies
Californias Medicaid Hospital Quality Assurance Fee Program


BUD
FY 2024 Appropriations bills
Nursing and allied health workforce funding
FY 2024 budget request
Further Continuing Appropriations and Other Extensions Act (H.R. 6363)
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act (H.R. 5894)
Tax Relief for American Families and Workers Act of 2024 (H.R. 7024)
Extension of Continuing Appropriations and Other Matters Act, 2024 (H.R. 7463)


Submitted Comments
Regulatory Comment Letters
SUBJECT: CMS-1808-P, Medicare and Medicaid Programs and the Childrens Health Insurance Program; Hospital Inpatient Prospective Payment Systems for Acute Care Hospitals and the Long-Term Care Hospital Prospective Payment System and Policy Changes and Fiscal Year 2025 Rates; Quality Programs Requirements; and Other Policy Changes; Proposed Rule, Federal Register (Vol. 89, No. 86), May 2, 2024
SUBJECT: CMS-4207-NC, Medicare Program; Request for Information on Medicare Advantage Data, Federal Register (Vol. 89, No. 20), January 30, 2024
SUBJECT: CMS-1806-P, Medicare Program; FFY 2025 Inpatient Psychiatric Facilities Prospective Payment System - Rate Update, Proposed Rule, Federal Register (Vol. 89, No. 65), April 3, 2024
SUBJECT: CMS-1804-P, Medicare Program; Inpatient Rehabilitation Facility Prospective Payment System for FFY 2025 and Updates to the IRF Quality Reporting Program; Proposed Rule, Federal Register (Vol. 89, No. 62), March 29, 2024
SUBJECT: Docket No. ATR 102 - Request for Information on Consolidation in Health Care Markets
SUBJECT: CMS-3367-P, Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflict of Interest, and Related Provisions, Proposed Rule, Federal Register (Vol 89, No 32), February 15, 2024
Legislative Comment Letters
Rep. Ami Bera Request for Information Regarding the Current State of Artificial Intelligence (AI) in the Health Care Industry, April 30, 2024
Senate Request for Information Regarding Draft SUSTAIN 340B Act, April 1, 2024

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Social Security Administration (SSA), Medicare Payment Advisory Commission (MedPAC)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Anne
O'Rourke
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)